Scholar Rock Holding Management
Management criteria checks 4/4
Scholar Rock Holding's CEO is Jay Backstrom, appointed in Oct 2022, has a tenure of 1.75 years. total yearly compensation is $4.11M, comprised of 15.2% salary and 84.8% bonuses, including company stock and options. directly owns 0.032% of the company’s shares, worth $228.85K. The average tenure of the management team and the board of directors is 2.3 years and 7.4 years respectively.
Key information
Jay Backstrom
Chief executive officer
US$4.1m
Total compensation
| CEO salary percentage | 15.2% |
| CEO tenure | 1.8yrs |
| CEO ownership | 0.03% |
| Management average tenure | 2.3yrs |
| Board average tenure | 7.4yrs |
Recent management updates
Recent updates
Health Check: How Prudently Does Scholar Rock Holding (NASDAQ:SRRK) Use Debt?
Apr 15
Scholar Rock: Solid Data And Good Prospects
Jan 12Scholar Rock Holding Corporation's (NASDAQ:SRRK) Share Price Not Quite Adding Up
Apr 19Scholar Rock: OLE Data In SMA Coupled With New CEO Make It A Buy
Oct 20Jay Backstrom is the new CEO at Scholar Rock
Sep 20Scholar Rock initiated at buy at Truist on platform for rare diseases and oncology
Jul 12Brokers Are Upgrading Their Views On Scholar Rock Holding Corporation (NASDAQ:SRRK) With These New Forecasts
May 21Broker Revenue Forecasts For Scholar Rock Holding Corporation (NASDAQ:SRRK) Are Surging Higher
Mar 08Scholar Rock Holding Corporation (NASDAQ:SRRK) Analysts Are More Bearish Than They Used To Be
May 15Is Scholar Rock Holding (NASDAQ:SRRK) Using Too Much Debt?
May 07If You Had Bought Scholar Rock Holding (NASDAQ:SRRK) Stock A Year Ago, You Could Pocket A 283% Gain Today
Mar 01We Think Scholar Rock Holding (NASDAQ:SRRK) Can Afford To Drive Business Growth
Jan 05
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$183m |
| Dec 31 2023 | US$4m | US$624k | -US$166m |
| Sep 30 2023 | n/a | n/a | -US$159m |
| Jun 30 2023 | n/a | n/a | -US$160m |
| Mar 31 2023 | n/a | n/a | -US$166m |
| Dec 31 2022 | US$7m | US$159k | -US$135m |
Compensation vs Market: Jay's total compensation ($USD4.11M) is about average for companies of similar size in the US market ($USD3.22M).
Compensation vs Earnings: Jay's compensation has been consistent with company performance over the past year.
CEO
Jay Backstrom (69 yo)
1.8yrs
Tenure
US$4,111,853
Compensation
Dr. Jay Thomas Backstrom, M.D., M.P.H., serves as Non-Executive Director of LAVA Therapeutics N.V. since June 2022. He serves as Director at Be Biopharma, Inc. since December 2021. He had served as a Direc...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.8yrs | US$4.11m | 0.032% $ 228.9k | |
| CFO, COO & Treasurer | 4yrs | US$2.01m | 0.051% $ 357.4k | |
| Chief Commercial Officer | 1.4yrs | US$2.28m | 0% $ 0 | |
| Chief Scientific Officer | less than a year | no data | 0.020% $ 138.0k | |
| Vice President of Corporate Affairs & Investor Relations | no data | no data | no data | |
| General Counsel & Corporate Secretary | 4.3yrs | US$2.13m | 0.093% $ 656.4k | |
| Chief Human Resources Officer | 2.9yrs | no data | 0.046% $ 327.7k | |
| Senior Vice President of Human Resources | no data | no data | no data | |
| Senior Vice President of Finance | no data | no data | no data | |
| Senior Vice President of Clinical Development & Operations | 4.3yrs | no data | no data | |
| Chief Medical Officer | 1.7yrs | no data | no data |
2.3yrs
Average Tenure
51.5yo
Average Age
Experienced Management: SRRK's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.8yrs | US$4.11m | 0.032% $ 228.9k | |
| Independent Director & Member of Scientific Advisory Board | 10.7yrs | US$299.20k | 0.047% $ 331.2k | |
| Member of Scientific Advisory Board | no data | US$48.97k | no data | |
| Independent Director & Member of Scientific Advisory Board | 7.8yrs | US$305.70k | 0.039% $ 276.6k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 9.9yrs | US$300.34k | 0.0067% $ 47.2k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Chairman of the Board | 7yrs | US$416.70k | 0.36% $ 2.6m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 3.3yrs | US$305.70k | 0% $ 0 |
7.4yrs
Average Tenure
69yo
Average Age
Experienced Board: SRRK's board of directors are considered experienced (7.4 years average tenure).